| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/14/1998 | US5780611 Oligonucleotide which binds with double-stranded promoter region of human collagen gene to form triple helix complex |
| 07/14/1998 | US5780607 Antisense oligomers |
| 07/14/1998 | US5780600 Purified ciliary neurotrophic factor |
| 07/14/1998 | US5780597 Monoclonal antibodies to cytotoxic lymphocyte maturation factor |
| 07/14/1998 | US5780596 Isolated binding protein used in detection of malignant cell types |
| 07/14/1998 | US5780595 Disulfide-bridged cyclic compounds containing the binding sequence homoarginine-glycine-aspartic acid |
| 07/14/1998 | US5780593 Method of isolating biomolecules by ion exchange |
| 07/14/1998 | US5780592 Transplant, antitumor |
| 07/14/1998 | US5780590 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 07/14/1998 | US5780589 Dipeptides, tripeptides or cyclic peptides as antagonist of opioid receptors treating drug abuse, drug dependence |
| 07/14/1998 | US5780588 Elucidation and synthesis of selected pentapeptides |
| 07/14/1998 | US5780587 Compounds and methods for inhibiting β-protein filament formation and neurotoxicity |
| 07/14/1998 | US5780585 Bacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic form |
| 07/14/1998 | US5780509 Compound bearing two, 2,6-diiodophenol-4-YL groups and diagnostic drug for iodine allergy |
| 07/14/1998 | US5780498 Endothelin receptor antagonists |
| 07/14/1998 | US5780484 Promoting repair of neuronal damage caused by disease of injury |
| 07/14/1998 | US5780454 Boronic ester and acid compounds |
| 07/14/1998 | US5780448 Administering expression vector |
| 07/14/1998 | US5780440 Treatment of pulmonary disease with protease inhibitors |
| 07/14/1998 | US5780439 Whey protein hydrolysates and mixtures thereof with casein and/or soy protein hydrolysates |
| 07/14/1998 | US5780438 Containing protein hydrolyzates; storage stable |
| 07/14/1998 | US5780436 Peptide compositions with growth factor-like activity |
| 07/14/1998 | US5780435 Administering luteinizing hormone releasing hormone antagonist; performing procedure that removes or destroys tumor |
| 07/14/1998 | US5780434 Composition for oral administration of peptides |
| 07/14/1998 | US5780433 Use of α-conotoxin MII to treat disorders resulting from nicotine stimulated dopamine release |
| 07/14/1998 | US5780432 Therapeutic method for treatment of carcinoma or autoimmune diseases |
| 07/14/1998 | US5780431 Peptide stable solution comprising a buffer and an alcohol to reduce inflammation and edema in mammals |
| 07/14/1998 | US5780429 Anti-LPS factor from horseshoe crabs and methods of use |
| 07/14/1998 | US5780426 Anticarcinogenic,-tumor, arthritic agents; osteoporosis; angiogenesis inhibitors; cyclic peptides having a non-arg-gly-asp binding sequence |
| 07/14/1998 | US5780303 Method and composition for treating thrombosis |
| 07/14/1998 | US5780300 Contacting human progenitor cells with agonist of notch function to inhibit differentiation of cells and exposing cells to conditions for proliferation |
| 07/14/1998 | US5780298 DNA encoding the sn-RNP-A antigen and fragments thereof |
| 07/14/1998 | US5780291 Wnt-x growth factor polypeptide, DNA encoding same, and Wnt-x antibody |
| 07/14/1998 | US5780287 Photoactivated antiviral and antitumor compositions |
| 07/14/1998 | US5780286 Arginase II |
| 07/14/1998 | US5780278 Nucleic acid encoding ?induced by contact with epithelium? (ice) protein of helicobacter pylori; diagnosis of gastrointestinal disorders |
| 07/14/1998 | US5780268 Polynucleotide; genetic engineering; medical diagnosis |
| 07/14/1998 | US5780265 Kunitz type plasma kallikrein inhibitors |
| 07/14/1998 | US5780264 Iron transport protein |
| 07/14/1998 | US5780263 Human CCN-like growth factor |
| 07/14/1998 | US5780262 Max-interacting proteins and related molecules and methods |
| 07/14/1998 | US5780245 Polypeptides having a serotonin receptor activity, nucleic acids coding for these polypeptides and uses |
| 07/14/1998 | US5780238 VPR receptor protein |
| 07/14/1998 | US5780235 Genetically engineered expression vectors; forming hybridization complex; detection |
| 07/14/1998 | US5780228 High affinity nucleic acid ligands to lectins |
| 07/14/1998 | US5780220 Methods and compositions for inhibiting HIV replication |
| 07/14/1998 | US5780040 Helicobacter pylori nickel binding protein |
| 07/14/1998 | US5780038 HIV-2 envelope polypeptides |
| 07/14/1998 | US5780034 Heat shock protein fragment polypeptide capable of suppressing autoimmune response against insulin-producing beta cells when administered to patient |
| 07/14/1998 | US5780033 Use of autoantibodies for tumor therapy and prophylaxis |
| 07/14/1998 | US5780030 Passive vaccine against Lyme disease |
| 07/14/1998 | US5780029 Murine antibodies; for modulation of immune response to high molecular weight melanoma associated antigen |
| 07/14/1998 | US5780027 Methods of treatment of down syndrome by interferon antagonists |
| 07/14/1998 | US5780025 Compositions and methods for the synthesis and assay of enkephalinase |
| 07/14/1998 | US5780024 Superoxide dismutase/tetanus toxin fragment C hybrid protein |
| 07/14/1998 | US5780021 Preventing or treating an autoimmune disorder and/or recurrent autoimmune disorder in a transplanted pancreatic or islet tissue in a mammal, which entails administering natural type 1 interferon, a synthetic type 1 interferon or hybrid |
| 07/14/1998 | US5780014 Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
| 07/14/1998 | US5780012 Method for reducing lung afflictions by inhalation of cytokine solutions |
| 07/14/1998 | US5780009 Milk production |
| 07/14/1998 | CA2223198A1 Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract |
| 07/14/1998 | CA2127330C Motilin-like polypeptides with gastrointestinal motor stimulating activity |
| 07/14/1998 | CA1339955C Process for transforming a human insulin precursor to human insulin |
| 07/14/1998 | CA1339954C Dogs - and horse - interferones |
| 07/10/1998 | CA2219960A1 Cdna clone he8cs41 that encodes a novel 7-transmembrane receptor |
| 07/10/1998 | CA2194814A1 Stimulation of protective t cells to prevent autoimmune disease |
| 07/09/1998 | WO1998029570A1 A METHOD OF PRODUCING A TEMPORALLY SPACED SUBTRACTED (TSS) cDNA LIBRARY AND USES THEREOF |
| 07/09/1998 | WO1998029566A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 07/09/1998 | WO1998029565A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 07/09/1998 | WO1998029555A2 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 07/09/1998 | WO1998029548A1 Human mage-like protein |
| 07/09/1998 | WO1998029547A1 Modulators of radial glia-astrocyte differentiation and transformation, and diagnostic and therapeutic uses thereof |
| 07/09/1998 | WO1998029546A1 Human rhombotin-like protein |
| 07/09/1998 | WO1998029544A1 Novel peptide, novel dna, and novel antibody |
| 07/09/1998 | WO1998029543A1 Compounds for modulating cell negative regulations and biological applications thereof |
| 07/09/1998 | WO1998029540A2 RECOMBINANT FUSION PROTEINS BASED ON RIBOSOME-INACTIVATING PROTEINS OF EUROPEAN MISTLETOE $i(VISCUM ALBUM) |
| 07/09/1998 | WO1998029453A1 Cell membrane-directed drugs |
| 07/09/1998 | WO1998029452A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use |
| 07/09/1998 | WO1998029451A1 Method for elevating the concentration of free insulin-like growth factor |
| 07/09/1998 | WO1998029450A1 Antigenic peptides reacting with anti-ovary antibodies |
| 07/09/1998 | WO1998029449A1 Novel human thioredoxin |
| 07/09/1998 | WO1998029448A1 Human pathogenesis-related protein |
| 07/09/1998 | WO1998029447A1 Novel human apoptosis regulator |
| 07/09/1998 | WO1998029446A1 Neuropeptides originating in scorpion |
| 07/09/1998 | WO1998029445A1 α-AMINO-BUTYRATE DERIVATIVES OF VENOMS |
| 07/09/1998 | WO1998029443A1 Multiple branch peptide constructions |
| 07/09/1998 | WO1998029438A2 Cortistatin polypeptides |
| 07/09/1998 | WO1998029437A2 Mammalian equilibrative nucleoside transporters |
| 07/09/1998 | WO1998029436A2 Lebetin peptides as platelet aggregation inhibitors |
| 07/09/1998 | WO1998029435A1 Peptidomimetic inhibitors of the human cytomegalovirus protease |
| 07/09/1998 | WO1998029430A1 G-rich oligo aptamers and methods of modulating an immune response |
| 07/09/1998 | WO1998029375A1 Brain targeted low molecular weight hydrophobic antioxidant compounds |
| 07/09/1998 | WO1998029141A1 Processes for spray drying solutions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes |
| 07/09/1998 | WO1998029140A1 Processes and compositions for spray drying hydrophobic drugs in organic solvent suspensions of hydrophilic excipients |
| 07/09/1998 | WO1998029138A2 Compositions and methods for tumour therapy |
| 07/09/1998 | WO1998029134A2 Microporation of tissue for delivery of bioactive agents |
| 07/09/1998 | WO1998029131A2 Aqueous glycerol formulations of somatotropin |
| 07/09/1998 | WO1998029130A1 Orthodontic remedy containing pth |
| 07/09/1998 | WO1998029124A1 Oligonucleotide compositions and methods for the modulation of the expression of b7 protein |
| 07/09/1998 | WO1998029123A1 Method of treating prostatic diseases using active vitamin d analogues |
| 07/09/1998 | WO1998029121A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |